Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 6(65), 2021
DOI: 10.1128/aac.01876-20
Links
Tools
Experience with Liposomal Amphotericin B in Outpatient Parenteral Antimicrobial Therapy
Journal article published in 2021 by
Yvonne J. Burnett 
,
Andrej Spec ,
Mohamed M. Ahmed,
William G. Powderly ,
Yasir Hamad
,
Andrej Spec ,
Mohamed M. Ahmed,
William G. Powderly ,
Yasir Hamad
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Outpatient parenteral antimicrobial therapy (OPAT) is a safe, effective, and convenient treatment strategy for patients receiving intravenous antimicrobials in the outpatient setting; however, data are limited describing the use and safety of liposomal amphotericin B (L-AMB). Records of patients receiving L-AMB OPAT between 1/1/2015 and 7/31/2018 were retrospectively reviewed.